Clavulanic Acid Production by Streptomyces clavuligerus: Insights from Systems Biology, Strain Engineering, and Downstream Processing

VA López-Agudelo, D Gómez-Ríos, H Ramirez-Malule - Antibiotics, 2021 - mdpi.com
Clavulanic acid (CA) is an irreversible β-lactamase enzyme inhibitor with a weak
antibacterial activity produced by Streptomyces clavuligerus (S. clavuligerus). CA is typically …

Targeted discovery of cryptic metabolites with antiproliferative activity

EJ Han, SR Lee, S Hoshino… - ACS chemical …, 2022 - ACS Publications
Microorganisms have provided a rich source of therapeutically valuable natural products.
Recent advances in whole genome sequencing and bioinformatics have revealed immense …

An integrative-omics analysis of an industrial clavulanic acid-overproducing Streptomyces clavuligerus

A Kurt-Kızıldoğan, G Çelik, E Ünsaldı, S Özcan… - Applied Microbiology …, 2022 - Springer
Clavulanic acid (CA) is a clinically important secondary metabolite used to treat infectious
diseases. We aimed to decipher complex regulatory mechanisms acting in CA biosynthesis …

Global regulator AdpA directly binds to tunicamycin gene cluster and negatively regulates tunicamycin biosynthesis in Streptomyces clavuligerus

Ç Otur, A Kurt-Kızıldoğan - World Journal of Microbiology and …, 2024 - Springer
Since a transcriptional regulator has yet to be identified within the tunicamycin biosynthetic
gene cluster in Streptomyces clavuligerus, we conducted a comprehensive investigation by …

Homologous expression of lysA encoding diaminopimelic acid (DAP) decarboxylase reveals increased antibiotic production in Streptomyces clavuligerus

Ç Otur, A Kurt-Kızıldoğan - Brazilian Journal of Microbiology, 2020 - Springer
Abstract lysA gene encoding meso-diaminopimelic acid (DAP) decarboxylase enzyme that
catalyzes l-lysine biosynthesis in the aspartate pathway in Streptomyces clavuligerus was …